vs
Loar Holdings Inc.（LOAR）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Loar Holdings Inc.的1.7倍（$219.9M vs $131.8M），Loar Holdings Inc.净利率更高（9.5% vs -1.0%，领先10.5%），Loar Holdings Inc.同比增速更快（19.3% vs 2.0%），过去两年Loar Holdings Inc.的营收复合增速更高（19.8% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
LOAR vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.7倍
$131.8M
营收增速更快
LOAR
高出17.3%
2.0%
净利率更高
LOAR
高出10.5%
-1.0%
两年增速更快
LOAR
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $131.8M | $219.9M |
| 净利润 | $12.5M | $-2.2M |
| 毛利率 | 52.1% | 71.1% |
| 营业利润率 | 18.0% | 0.2% |
| 净利率 | 9.5% | -1.0% |
| 营收同比 | 19.3% | 2.0% |
| 净利润同比 | 239.5% | 92.4% |
| 每股收益（稀释后） | $0.13 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LOAROFIX
| Q4 25 | $131.8M | $219.9M | ||
| Q3 25 | $126.8M | $205.6M | ||
| Q2 25 | $123.1M | $203.1M | ||
| Q1 25 | $114.7M | $193.6M | ||
| Q4 24 | $110.4M | $215.7M | ||
| Q3 24 | $103.5M | $196.6M | ||
| Q2 24 | $97.0M | $198.6M | ||
| Q1 24 | $91.8M | $188.6M |
净利润LOAROFIX
| Q4 25 | $12.5M | $-2.2M | ||
| Q3 25 | $27.6M | $-22.8M | ||
| Q2 25 | $16.7M | $-14.1M | ||
| Q1 25 | $15.3M | $-53.1M | ||
| Q4 24 | $3.7M | $-29.1M | ||
| Q3 24 | $8.7M | $-27.4M | ||
| Q2 24 | $7.6M | $-33.4M | ||
| Q1 24 | $2.2M | $-36.0M |
毛利率LOAROFIX
| Q4 25 | 52.1% | 71.1% | ||
| Q3 25 | 52.7% | 72.2% | ||
| Q2 25 | 53.8% | 68.7% | ||
| Q1 25 | 52.1% | 62.8% | ||
| Q4 24 | 48.9% | 69.0% | ||
| Q3 24 | 51.1% | 68.7% | ||
| Q2 24 | 49.0% | 67.8% | ||
| Q1 24 | 48.4% | 67.5% |
营业利润率LOAROFIX
| Q4 25 | 18.0% | 0.2% | ||
| Q3 25 | 22.9% | -8.3% | ||
| Q2 25 | 22.2% | -7.9% | ||
| Q1 25 | 22.8% | -25.2% | ||
| Q4 24 | 19.2% | -5.3% | ||
| Q3 24 | 22.1% | -9.6% | ||
| Q2 24 | 22.9% | -12.5% | ||
| Q1 24 | 23.3% | -15.6% |
净利率LOAROFIX
| Q4 25 | 9.5% | -1.0% | ||
| Q3 25 | 21.8% | -11.1% | ||
| Q2 25 | 13.6% | -6.9% | ||
| Q1 25 | 13.4% | -27.4% | ||
| Q4 24 | 3.3% | -13.5% | ||
| Q3 24 | 8.4% | -13.9% | ||
| Q2 24 | 7.9% | -16.8% | ||
| Q1 24 | 2.4% | -19.1% |
每股收益（稀释后）LOAROFIX
| Q4 25 | $0.13 | $-0.05 | ||
| Q3 25 | $0.29 | $-0.57 | ||
| Q2 25 | $0.17 | $-0.36 | ||
| Q1 25 | $0.16 | $-1.35 | ||
| Q4 24 | $-11023.48 | $-0.76 | ||
| Q3 24 | $0.09 | $-0.71 | ||
| Q2 24 | $0.09 | $-0.88 | ||
| Q1 24 | $11023.54 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $84.8M | $82.0M |
| 总债务越低越好 | $715.7M | — |
| 股东权益账面价值 | $1.2B | $450.0M |
| 总资产 | $2.0B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.61× | — |
8季度趋势，按日历期对齐
现金及短期投资LOAROFIX
| Q4 25 | $84.8M | $82.0M | ||
| Q3 25 | $99.0M | $62.9M | ||
| Q2 25 | $103.3M | $65.6M | ||
| Q1 25 | $80.5M | $58.0M | ||
| Q4 24 | $54.1M | $83.2M | ||
| Q3 24 | $55.2M | $30.1M | ||
| Q2 24 | $73.2M | $26.4M | ||
| Q1 24 | $28.2M | $27.0M |
总债务LOAROFIX
| Q4 25 | $715.7M | — | ||
| Q3 25 | $279.4M | $157.2M | ||
| Q2 25 | $277.7M | $157.0M | ||
| Q1 25 | $277.5M | $156.9M | ||
| Q4 24 | $277.3M | $157.0M | ||
| Q3 24 | $602.1M | $118.5M | ||
| Q2 24 | $250.7M | $118.0M | ||
| Q1 24 | $534.2M | $118.2M |
股东权益LOAROFIX
| Q4 25 | $1.2B | $450.0M | ||
| Q3 25 | $1.2B | $442.5M | ||
| Q2 25 | $1.1B | $458.3M | ||
| Q1 25 | $1.1B | $458.3M | ||
| Q4 24 | $1.1B | $503.1M | ||
| Q3 24 | $769.8M | $525.9M | ||
| Q2 24 | $758.4M | $546.0M | ||
| Q1 24 | $420.6M | $570.3M |
总资产LOAROFIX
| Q4 25 | $2.0B | $850.6M | ||
| Q3 25 | $1.5B | $832.6M | ||
| Q2 25 | $1.5B | $837.2M | ||
| Q1 25 | $1.5B | $823.1M | ||
| Q4 24 | $1.5B | $893.3M | ||
| Q3 24 | $1.5B | $867.9M | ||
| Q2 24 | $1.1B | $882.0M | ||
| Q1 24 | $1.1B | $906.0M |
负债/权益比LOAROFIX
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.24× | 0.36× | ||
| Q2 25 | 0.25× | 0.34× | ||
| Q1 25 | 0.25× | 0.34× | ||
| Q4 24 | 0.25× | 0.31× | ||
| Q3 24 | 0.78× | 0.23× | ||
| Q2 24 | 0.33× | 0.22× | ||
| Q1 24 | 1.27× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $30.4M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | 2.43× | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流LOAROFIX
| Q4 25 | $30.4M | $27.7M | ||
| Q3 25 | $29.7M | $12.4M | ||
| Q2 25 | $23.8M | $11.6M | ||
| Q1 25 | $28.4M | $-18.4M | ||
| Q4 24 | $20.7M | $23.7M | ||
| Q3 24 | $16.3M | $11.7M | ||
| Q2 24 | $7.1M | $9.0M | ||
| Q1 24 | $10.8M | $-18.6M |
自由现金流LOAROFIX
| Q4 25 | — | $16.8M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $-360.0K | ||
| Q1 24 | — | $-29.1M |
自由现金流率LOAROFIX
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | -0.2% | ||
| Q1 24 | — | -15.4% |
资本支出强度LOAROFIX
| Q4 25 | — | 4.9% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 4.7% | ||
| Q1 24 | — | 5.6% |
现金转化率LOAROFIX
| Q4 25 | 2.43× | — | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 1.42× | — | ||
| Q1 25 | 1.85× | — | ||
| Q4 24 | 5.62× | — | ||
| Q3 24 | 1.89× | — | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 4.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LOAR
| Other | $76.8M | 58% |
| Commercial Aerospace | $21.2M | 16% |
| Business Jet And General Aviation | $17.6M | 13% |
| Defense | $16.2M | 12% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
